BIOINFRA Life Science aims to lead the global bio-market and contribute to human health.
Founded in 2001, BIOINFRA Life Science has come to possess a global level of technology by uncovering biomarkers, which are the core technology of the biomedical field, and by creatively attempting the convergence of bioinformatics. Furthermore, BIOINFRA Life Science is currently developing cancer gene treatments and technologies that systematically monitor the possibility of metastasis and recurrence in blood for cancer patients. This is an aim carried out to contribute to the promotion of human health and to play our part in eradicating cancer, a disease that is on the increase in an aging society.
The business line of BIOINFRA Life Science is aimed at integrated precision medicine which goes beyond the commonly used categories of diagnostic devices, reagent development, and molecular diagnosis. A combination of global source technologies, research know-how, expert management, and a research team devoted night and day to research and experiments aims at becoming a leading company in not only the domestic bio industry but also the global bio industry.
As a representative of the executives and staff, I sincerely thank you for your continued interest and encouragement for our company.